Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP26762.RANLWxJU46-eyVg5BtkQ08cNFF3Co-AluhiYSJKwtwM_s130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP26762.RANLWxJU46-eyVg5BtkQ08cNFF3Co-AluhiYSJKwtwM_s130_assertion type Assertion NP26762.RANLWxJU46-eyVg5BtkQ08cNFF3Co-AluhiYSJKwtwM_s130_head.
- NP26762.RANLWxJU46-eyVg5BtkQ08cNFF3Co-AluhiYSJKwtwM_s130_assertion description "[Thus, apart from inhibition of ET-1 production, PPARalpha activation exerts protective actions in hypertension via a mechanism that involves NO production and/or inhibition of NAD(P)H oxidase activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP26762.RANLWxJU46-eyVg5BtkQ08cNFF3Co-AluhiYSJKwtwM_s130_provenance.
- NP26762.RANLWxJU46-eyVg5BtkQ08cNFF3Co-AluhiYSJKwtwM_s130_assertion evidence source_evidence_curated NP26762.RANLWxJU46-eyVg5BtkQ08cNFF3Co-AluhiYSJKwtwM_s130_provenance.
- NP26762.RANLWxJU46-eyVg5BtkQ08cNFF3Co-AluhiYSJKwtwM_s130_assertion SIO_000772 16054168 NP26762.RANLWxJU46-eyVg5BtkQ08cNFF3Co-AluhiYSJKwtwM_s130_provenance.
- NP26762.RANLWxJU46-eyVg5BtkQ08cNFF3Co-AluhiYSJKwtwM_s130_assertion wasDerivedFrom ctd_human-20150221 NP26762.RANLWxJU46-eyVg5BtkQ08cNFF3Co-AluhiYSJKwtwM_s130_provenance.
- NP26762.RANLWxJU46-eyVg5BtkQ08cNFF3Co-AluhiYSJKwtwM_s130_assertion wasGeneratedBy ECO_0000218 NP26762.RANLWxJU46-eyVg5BtkQ08cNFF3Co-AluhiYSJKwtwM_s130_provenance.